Patents by Inventor Ian Cottingham

Ian Cottingham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ADMINISTRATION OF A SELECTIVE IL-6-TRANS-SIGNALLING INHIBITOR
    Publication number: 20170320932
    Abstract: A selective IL-6-trans-signalling inhibitor can be used to treat a variety of IL-6-mediated conditions, including inflammatory diseases and cancer. The inhibitor can safely be administered to humans at a variety of doses. Moreover, the inhibitor lessens deleterious effects associated with other IL-6 inhibitors such as lowering neutrophil counts, platelet counts and levels of C-reactive protein.
    Type: Application
    Filed: December 1, 2015
    Publication date: November 9, 2017
    Inventors: Ian Cottingham, Niclas Axel Petri
  • Pharmaceutical preparation
    Patent number: 9771407
    Abstract: Preparations including recombinant FSH (rFSH).
    Type: Grant
    Filed: August 16, 2016
    Date of Patent: September 26, 2017
    Assignee: Ferring International Center SA
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • Pharmaceutical preparation
    Patent number: 9757469
    Abstract: Polyethylene glycol modified human chorionic gonadotropin (hCG), preparations thereof, compositions thereof, and methods of preparation and use thereof are described.
    Type: Grant
    Filed: March 29, 2012
    Date of Patent: September 12, 2017
    Assignee: Ferring B.V.
    Inventors: Ian Cottingham, Daniel Plaksin, Jenny Aharanov
  • Pharmaceutical preparation comprising recombinant HcG
    Patent number: 9676835
    Abstract: The present disclosure describes recombinant human chorionic gonadotropin (hCG) and methods for the production thereof. The recombinant hCG can include ?2,3, ?2,6, and, optionally, ?2,8 sialylation. The recombinant hCG can be produced in a human cell line such as a PER.C6® cell line.
    Type: Grant
    Filed: May 21, 2014
    Date of Patent: June 13, 2017
    Assignee: Ferring B.V.
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • Recombinant FSH including alpha 2,3- and alpha 2,6-sialylation
    Patent number: 9546204
    Abstract: Preparations including recombinant FSH (rFSH).
    Type: Grant
    Filed: November 14, 2014
    Date of Patent: January 17, 2017
    Assignee: Ferring International Center SA
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • PHARMACEUTICAL PREPARATION
    Publication number: 20160347811
    Abstract: Preparations including recombinant FSH (rFSH).
    Type: Application
    Filed: August 16, 2016
    Publication date: December 1, 2016
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • Pharmaceutical preparation comprising recombinant hCG
    Patent number: 8975226
    Abstract: The present disclosure describes recombinant human chorionic gonadotropin (hCG) and methods for the production thereof. The recombinant hCG can include ?2,3, ?2,6, and, optionally, ?2,8 sialylation. The recombinant hCG can be produced in a human cell line such as a PER.C6® cell line.
    Type: Grant
    Filed: October 4, 2010
    Date of Patent: March 10, 2015
    Assignee: Ferring B.V.
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • Recombinant FSH Including Alpha 2,3- and Alpha 2,6-Sialylation
    Publication number: 20150065695
    Abstract: Preparations including recombinant FSH (rFSH).
    Type: Application
    Filed: November 14, 2014
    Publication date: March 5, 2015
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • Recombinant FSH including alpha 2,3- and alpha 2,6-sailylation
    Patent number: 8951967
    Abstract: The present disclosure describes recombinant follicle stimulating hormone (FSH) and methods for the production thereof. The recombinant FSH can include ?2,3, ?2,6, and, optionally, ?2,8 sialylation. The recombinant FSH can be produced in a human cell line such as a PER.C6® cell line.
    Type: Grant
    Filed: April 16, 2009
    Date of Patent: February 10, 2015
    Assignee: Ferring International Center SA
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • Pharmaceutical Preparation Comprising Recombinant HcG
    Publication number: 20140249082
    Abstract: The present disclosure describes recombinant human chorionic gonadotropin (hCG) and methods for the production thereof. The recombinant hCG can include ?2,3, ?2,6, and, optionally, ?2,8 sialylation. The recombinant hCG can be produced in a human cell line such as a PER.C6® cell line.
    Type: Application
    Filed: May 21, 2014
    Publication date: September 4, 2014
    Applicant: Ferring B.V.
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • PHARMACEUTICAL PREPARATION
    Publication number: 20140088010
    Abstract: Preparations including poly (ethylene glycol) modified recombinant hCG(rhCG).
    Type: Application
    Filed: March 29, 2012
    Publication date: March 27, 2014
    Applicant: FERRING B.V.
    Inventors: Ian Cottingham, Daniel Plaksin, Jenny Aharanov
  • Pharmaceutical Preparation Comprising Recombinant HCG
    Publication number: 20130023476
    Abstract: Preparations including recombinant hCG (r hCG).
    Type: Application
    Filed: October 4, 2010
    Publication date: January 24, 2013
    Applicant: FERRING B.V.
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White
  • RECOMBINANT FSH INCLUDING ALPHA 2,3- AND ALPHA 2,6-SAILYLATIO
    Publication number: 20110105398
    Abstract: Preparations including recombinant FSH (rFSH).
    Type: Application
    Filed: April 16, 2009
    Publication date: May 5, 2011
    Applicant: Ferring International Center SA
    Inventors: Ian Cottingham, Daniel Plaksin, Richard Boyd White